Owens & Minor (NYSE:OMI - Get Free Report) issued an update on its FY24 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $1.45-1.55 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $10.6-10.8 billion, compared to the consensus revenue estimate of $10.71 billion. Owens & Minor also updated its FY 2024 guidance to 1.450-1.550 EPS.
Analysts Set New Price Targets
Several equities analysts have weighed in on the company. Citigroup raised Owens & Minor from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $24.00 to $19.00 in a report on Friday, July 19th. StockNews.com downgraded shares of Owens & Minor from a "buy" rating to a "hold" rating in a research note on Monday, August 26th. Robert W. Baird cut their price target on shares of Owens & Minor from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Tuesday, July 16th. JPMorgan Chase & Co. decreased their price objective on shares of Owens & Minor from $22.00 to $18.00 and set an "underweight" rating on the stock in a research note on Wednesday, August 21st. Finally, Barclays cut their target price on Owens & Minor from $23.00 to $18.00 and set an "equal weight" rating for the company in a research note on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, Owens & Minor presently has a consensus rating of "Hold" and an average price target of $20.00.
Read Our Latest Analysis on Owens & Minor
Owens & Minor Trading Down 10.2 %
Owens & Minor stock traded down $1.36 during trading hours on Monday, reaching $12.00. 2,051,715 shares of the company's stock were exchanged, compared to its average volume of 832,902. The firm has a market capitalization of $925.20 million, a PE ratio of -21.43, a PEG ratio of 0.41 and a beta of 0.41. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.17. The firm's 50 day simple moving average is $14.62 and its 200 day simple moving average is $16.28. Owens & Minor has a twelve month low of $11.75 and a twelve month high of $28.35.
Owens & Minor (NYSE:OMI - Get Free Report) last posted its earnings results on Friday, August 2nd. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.03. The company had revenue of $2.67 billion for the quarter, compared to analyst estimates of $2.65 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. The firm's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.18 EPS. Research analysts predict that Owens & Minor will post 1.57 earnings per share for the current year.
Owens & Minor Company Profile
(
Get Free Report)
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading
Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.